Whether a microbiome test is useful during menopause cannot be clearly answered based on current evidence. Hormonal shifts do affect the gut microbiota, and some studies suggest links between microbial composition and menopausal symptoms such as hot flashes or weight gain. However, robust clinical trials demonstrating that microbiome testing improves outcomes in menopause are lacking. Most direct-to-consumer (DTC) kits rely on general reference populations rather than menopause-specific norms. Furthermore, analytical methods are poorly standardized, as illustrated by the limitations of SIBO breath tests (PMID:40731137, PMID:26636484). Without medical supervision and evidence-based action plans, such tests remain largely marketing-driven. A comprehensive metabolic workup (e.g., blood lipids, glucose) or hormone assessment currently offers greater clinical value. Conclusion: utility is unclear, evidence is weak. Consumers should remain cautious and consult a healthcare professional.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-70f793fb2e3716da84870337